CrossChx raises capital in Series B round
Clients CrossChx, Inc.
Jones Day represented CrossChx, Inc., a provider of biometric solutions to prevent medical identity fraud, improve health outcomes, and enable a nationwide health information exchange, in connection with its issuance of $15 million of Series B Convertible Preferred Stock in a private placement to Drive Capital and Khosla Ventures.